NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Niki BioSolutions, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)
Close on Oct 19, 2026
- Market cap
- $16.66M
- P/E (TTM)
- –
- Dividend yield
- –
Niki BioSolutions statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Measuring & Controlling Devices, NEC companies for comparison
Valuation
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Market Cap | $16.94M | $230.55M |
| Enterprise Value | $4.12M | $202.97M |
| PB Ratio | 0.73 | 3.04 |
| P/TBV Ratio | 0.73 | 4.43 |
Income (trailing twelve months)
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Net Income | -$1.36M | -$6.57M |
| EPS (Diluted) | -$0.19 | -$0.08 |
Returns
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Return on Equity (ROE) | -6.16% | -18.2% |
| Return on Assets (ROA) | -7.83% | -13.3% |
Balance sheet
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.45M | $36.66M |
| Net Cash (Debt) | $3.45M | $3.92M |
| Net Cash Per Share | $0.42 | $0.28 |
| Equity (Book Value) | $23.12M | $55.33M |
| Book Value Per Share | $2.84 | $2.87 |
| Tangible Book Value | $23.12M | $10.79M |
| Working Capital | -$1.00M | $56.72M |
Financial position
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Current Ratio | 0.78 | 2.48 |
| Quick Ratio | 0.75 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.84M | -$566.22K |
Efficiency
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Profits Per Employee | -$681.64K | -$51.88K |
| Employee Count | 2 | 185 |
Dividends and yields
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Earnings Yield | -8.05% | -6.88% |
| Buyback Yield | -18.1% | 0.78% |
| Shareholder Yield | -18.1% | 0.80% |
Shares
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Shares Outstanding | 8,143,760 | 44,302,700 |
| Shares Change (YoY) | 34.8% | 3.36% |
| Float | 6,619,550 | 37,462,700 |
| Shares Held by Insiders | 18.7% | 10.5% |
Scores
| Measure | Niki BioSolutions | Industry median |
|---|---|---|
| Altman Z-Score | -3.52 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Niki BioSolutions's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.